Personalizing #mHSPC treatment: Doublet therapy for elderly, low-volume metastatic #ProstateCancer. @neerajaiims @huntsmancancer and @zklaassen_md @GACancerCenter discuss real-world decision-making for metachronous metastatic hormone-sensitive prostate cancer through an
